In this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.
Caitlin M. Sacco, PharmD Candidate
Advertisement
Articles by Caitlin M. Sacco, PharmD Candidate
Current cancer research focuses heavily on adjunct immunotherapy in combination with traditional chemotherapy.
Advertisement
Latest Updated Articles
Managing Hematologic Cancer Therapies and Reducing COVID-19 RiskPublished: April 3rd 2021 | Updated:
Improving Outcomes for Patients With Breast CancerPublished: February 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Experts Highlight Key Sessions and Emerging Topics from The Menopause Society 2025 Annual Meeting
5
